Patni Rajiv - Insider Non-Derivative Transactions at REATA PHARMACEUTICALS INC (RETA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 26, 2023, Patni Rajiv's relationship to REATA PHARMACEUTICALS INC (RETA) is Officer (EVP, Chief R&D Officer), and currently has 0 shares of Class A common stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RETA insiders.
Data Source: SEC.
Patni Rajiv - Insider Non-Derivative Transactions of RETA Class A common stock
Patni Rajiv - Insider Non-Derivative Transactions at RETA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 27, 2023 | Disposition -- (Class A common stock) | 45000 | 0 | 0 |
| Jun 13, 2023 | Acquisition -- (Class A common stock) | 45000 | 0 | 45000 |